Suppr超能文献

诱导多能干细胞技术与糖尿病的干细胞治疗

Induced pluripotent stem cell technology and stem cell therapy for diabetes.

作者信息

Drummond Robert J, Kunath Tilo, Mee P Joseph, Ross James A

机构信息

Tissue Injury and Repair Group, MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, Scotland EH16 4SB;

出版信息

Exp Ther Med. 2011 Jan;2(1):3-7. doi: 10.3892/etm.2010.173. Epub 2010 Dec 2.

Abstract

Although diabetes can be managed clinically with the use of insulin injections, it remains an incurable and inconvenient disorder. In the long-term, it is associated with a number of clinical complications, such as cardiovascular disease, resulting in a desire for the development of new methodologies to replace defective cells and provide a lasting normality without the need for drug treatment. Stem cells, including induced pluripotent stem cells, offer the possibility of generating cells suitable for transplantation due to their capacity to differentiate into all tissue lineages. However, many issues must be addressed before this type of treatment becomes a reality, including the need for a greater understanding of the underlying biology involved in the onset of diabetes.

摘要

尽管糖尿病可以通过注射胰岛素进行临床治疗,但它仍然是一种无法治愈且不便的疾病。从长远来看,它会引发许多临床并发症,如心血管疾病,这使得人们渴望开发新方法来替代有缺陷的细胞,并在无需药物治疗的情况下实现持久的正常状态。干细胞,包括诱导多能干细胞,因其能够分化为所有组织谱系,提供了生成适合移植细胞的可能性。然而,在这种治疗成为现实之前,必须解决许多问题,包括需要更深入地了解糖尿病发病背后的生物学机制。

相似文献

本文引用的文献

2
Generation of pluripotent stem cells from patients with type 1 diabetes.从1型糖尿病患者中生成多能干细胞。
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15768-73. doi: 10.1073/pnas.0906894106. Epub 2009 Aug 31.
4
Generation of induced pluripotent stem cells using recombinant proteins.利用重组蛋白生成诱导多能干细胞。
Cell Stem Cell. 2009 May 8;4(5):381-4. doi: 10.1016/j.stem.2009.04.005. Epub 2009 Apr 23.
5
A fresh look at iPS cells.对诱导多能干细胞的全新审视。
Cell. 2009 Apr 3;137(1):13-7. doi: 10.1016/j.cell.2009.03.034.
6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验